bpc 157 clinical trial serbia BPC-157+TB500 10mg | Research Peptide Blend BPC-157 FDA Approval Status: Is
Description
Strict quality assurance is maintained
That matters because the marketplace often blurs TB-500 with full-length thymosin beta-4 and sells both under the same umbrella
The single-dose toxicity study revealed no test-related effects in the organs of treated animals, further supporting its safety
None of these have been formally measured in a controlled study of the blend
